Purchase Order 36C24122P0078
Award Date 10/21/21
Potential Completion Date 10/20/22
Potential Value $507K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Haven, CT 06516, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Sofie Co., a subsidiary of Sofie Biosciences, Inc., was awarded a $453,128 firm fixed price delivery order against the VHA Pharmaceutical Prime Vendor contract to provide Pylarify Piflufolastat F18 radiopharmaceuticals for the Veterans Integrated Service Network 12 region. The one year contract runs from October 2021 through July 2022 and has no set aside designation. The Department of Veterans Affairs Veterans Health Administration will utilize the radiopharmaceuticals in medical imaging...
- The Department of Veterans Affairs (VA) awarded a $1,198,895.04 firm fixed-price purchase order contract to Sofie CO., a small business prime contractor, for the purchase and delivery of the radiopharmaceutical PYLARIFY (Piflufolastat F-18 Injection) over a one-year period. This contract supports the VA's Veterans Health Administration and Veterans Integrated Service Network 5 for radiology services at the DC VA Medical Center. Sofie CO., a subsidiary of Sofie Biosciences, Inc., is an...
- The Department of Veterans Affairs Veterans Health Administration awarded a $176,398.24 firm fixed price purchase order to Sofie CO. for the delivery of the radiopharmaceutical PYLARIFY. The contract has a completion date of May 31, 2022 and does not utilize a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics, with extensive experience in PET imaging. The company has received multiple federal...
- The U.S. Department of Veterans Affairs (VA) awarded a $75,783.12 firm-fixed-price purchase order contract to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PYLARIFY, a radiopharmaceutical used in prostate cancer detection. This contract is part of Sofie's broader supply of specialized imaging agents, pharmaceuticals, and related services to various federal agencies, including the VA, Defense Health Agency, and National Institutes of Health. Sofie has...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 (VA - VHA) awarded a Blanket Purchase Agreement Call contract valued at $1,062,076.02 to Sofie CO., doing business as Sofie and a wholly owned subsidiary of Sofie Biosciences, Inc., to provide PYLARIS products and services. The contract has a period of performance from March 4, 2022 through March 31, 2023 and utilizes a firm fixed price contract type. Place of performance will be Sterling,...
- Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a $83,904 firm fixed price delivery order against the VHA Pharmaceutical Prime Vendor (PPV) contract to provide Pylarify Piflufolasta F18 radiopharmaceuticals for use in positron emission tomography imaging by the Veterans Health Administration Veterans Integrated Service Network 12 in Sterling, Virginia. The contract has a period of performance through September 30, 2021 and no set-aside designation was used for this award....
- This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $204,375.00 firm-fixed-price purchase order is for the supply of radiopharmaceutical products. The contract does not have a set-aside designation. Sofie CO. is a specialized provider of molecular diagnostics and therapeutics, including radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies such as the VA, Defense Health Agency...
- This federal contract award is for the provision of PYLARIFY radiopharmaceuticals and related services to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2). The prime contractor is Sofie CO., a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics. The $1,681,341.42 firm-fixed-price delivery order contract supports the VA's medical imaging and cancer treatment programs, enabling the...
- Sofie CO., doing business as IBA Molecular, was awarded a $241,784.24 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 5 on August 1, 2023, for delivery of PYLARIFY (piflufolastat F-18), a radioactive pharmaceutical used in positron emission tomography imaging for prostate cancer detection. The contract is designated as a total small business set-aside and specifies performance in Sterling, Virginia, with an ultimate completion date of...
- This federal contract award, with an ID of 36C25521P0656, was made by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of PYLARIFY (piflufolastat F-18) injection, a radiopharmaceutical used for positron emission tomography (PET) imaging of prostate cancer. The contract has a ceiling value of $97,888.00 and is a firm-fixed-price purchase order, with an...